Sfoglia per Autore
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer
2022 Gianni, Caterina; Palleschi, Michela; Merloni, Filippo; Di Menna, Giandomenico; Sirico, Marianna; Sarti, Samanta; Virga, Alessandra; Ulivi, Paola; Cecconetto, Lorenzo; Mariotti, Marita; De Giorgi, Ugo
Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment
2022 Gianni C.; Palleschi M.; Schepisi G.; Casadei C.; Bleve S.; Merloni F.; Sirico M.; Sarti S.; Cecconetto L.; Di Menna G.; Schettini F.; De Giorgi U.
Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis
2022 Rossi T.; Angeli D.; Tebaldi M.; Fici P.; Rossi E.; Rocca A.; Palleschi M.; Maltoni R.; Martinelli G.; Fabbri F.; Gallerani G.
Real-world experience and clinical impact of drug-drug interactions in HR+/HER2- advanced breast cancer patients treated with abemaciclib plus endocrine therapy: the AB-ITALY study
2023 Pisegna, S.; Scagnoli, S.; Toss, A.; Caputo, R.; De Laurentiis, M.; Palleschi, M.; De Giorgi, U.; Cortesi, E.; Fabbri, M.A.; Fabi, A.; Paris, I.; Orlandi, A.; Curigliano, G.; Criscitiello, C.; Garrone, O.; Tomasello, G.; D{'}Auria, G.; Vici, P.; Ricevuto, E.; Domati, F.; Piombino, C.; Parola, S.; Scafetta, R.; Cirillo, A.; Salimbeni, B.T.; Di Lisa, F.S.; Strigari, L.; Preissner, R.; Simmaco, M.; Santini, D.; Marchetti, P.; Botticelli, A.
Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure
2023 Merloni, Filippo; Palleschi, Michela; Casadei, Chiara; Romeo, Antonino; Curcio, Annalisa; Casadei, Roberto; Stella, Franco; Ercolani, Giorgio; Gianni, Caterina; Sirico, Marianna; Cima, Simona; Sarti, Samanta; Cecconetto, Lorenzo; Di Menna, Giandomenico; De Giorgi, Ugo
The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer
2023 Schepisi G.; Gianni C.; Palleschi M.; Bleve S.; Casadei C.; Lolli C.; Ridolfi L.; Martinelli G.; De Giorgi U.
Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer
2023 Gianni C.; Palleschi M.; Merloni F.; Bleve S.; Casadei C.; Sirico M.; Di Menna G.; Sarti S.; Cecconetto L.; Mariotti M.; De Giorgi U.
Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology
2023 Merloni F.; Palleschi M.; Gianni C.; Casadei C.; Curcio A.; Romeo A.; Rocchi M.; Cima S.; Sirico M.; Sarti S.; Cecconetto L.; Mariotti M.; Di Menna G.; De Giorgi U.
Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical Trial.
2023 Munzone E, Regan MM, Cinieri S, Montagna E, Orlando L, Shi R, Campadelli E, Gianni L, Palleschi M, Petrelli F, Bengala C, Generali D, Collovà E, Puglisi F, Cretella E, Zamagni C, Chini C, Ruepp B, Loi S, Colleoni M; International Breast Cancer Study Group (IBCSG).
Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives
2023 Sirico, Marianna; Virga, Alessandra; Conte, Benedetta; Urbini, Milena; Ulivi, Paola; Gianni, Caterina; Merloni, Filippo; Palleschi, Michela; Gasperoni, Marco; Curcio, Annalisa; Saha, Debjani; Buono, Giuseppe; Muñoz, Montserrat; De Giorgi, Ugo; Schettini, Francesco
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy
2024 Roberta Maltoni; Andrea Roncadori; William Balzi; Massimiliano Mazza; Fabio Nicolini; Michela Palleschi; Paola Ulivi; Sara Bravaccini
Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): Pilot study with 18F-Fluoroestradiol (18F-FES) CT/PET
In corso di stampa A. Gennari, E. Brain, A. De Censi, O. Nanni, R. Wuerstlein, A. Frassoldati, J. Cortes, V. Rossi, M. Palleschi, J.L. Alberini, F. Matteucci, A. Piccardo, G. Sacchetti, H. Ilhan, F. D’Avanzo, B. Ruffilli, S. Nardin, M. Monti, M. Puntoni, V. Fontana, L. Boni, N. Harbeck,
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study
In corso di stampa Botticelli A, Caputo R, Scagnoli S, Pisegna S, De Laurentiis M, Curigliano G, Lambertini M, Pantano F, Palazzo A, Paris I, Vernieri C, Tedesco B, Giampaglia M, Palleschi M, Ballatore Z, Alesini D, D'Auria G, Fabbri A, Rossi L, Verrazzo A, Scafetta R, Marinelli D, Sposetti C, Barberi V, Strigari L, Marchetti P, Santini D, Fabi A.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer | Gianni, Caterina; Palleschi, Michela; Merloni, Filippo; Di Menna, Giandomenico; Sirico, Marianna;... Sarti, Samanta; Virga, Alessandra; Ulivi, Paola; Cecconetto, Lorenzo; Mariotti, Marita; De Giorgi, Ugo | 2022-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | graphic.pdf; ijms-23-14197.pdf |
| Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment | Gianni C.; Palleschi M.; Schepisi G.; Casadei C.; Bleve S.; Merloni F.; Sirico M.; Sarti S.; Cecc...onetto L.; Di Menna G.; Schettini F.; De Giorgi U. | 2022-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis | Rossi T.; Angeli D.; Tebaldi M.; Fici P.; Rossi E.; Rocca A.; Palleschi M.; Maltoni R.; Martinell...i G.; Fabbri F.; Gallerani G. | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-14-03925-v2.pdf; cancers-14-03925-s001.zip |
| Real-world experience and clinical impact of drug-drug interactions in HR+/HER2- advanced breast cancer patients treated with abemaciclib plus endocrine therapy: the AB-ITALY study | Pisegna, S.; Scagnoli, S.; Toss, A.; Caputo, R.; De Laurentiis, M.; Palleschi, M.; De Giorgi, U.;... Cortesi, E.; Fabbri, M.A.; Fabi, A.; Paris, I.; Orlandi, A.; Curigliano, G.; Criscitiello, C.; Garrone, O.; Tomasello, G.; D{'}Auria, G.; Vici, P.; Ricevuto, E.; Domati, F.; Piombino, C.; Parola, S.; Scafetta, R.; Cirillo, A.; Salimbeni, B.T.; Di Lisa, F.S.; Strigari, L.; Preissner, R.; Simmaco, M.; Santini, D.; Marchetti, P.; Botticelli, A. | 2023-01-01 | ANNALS OF ONCOLOGY | - | 1.06 Abstract in rivista | - |
| Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure | Merloni, Filippo; Palleschi, Michela; Casadei, Chiara; Romeo, Antonino; Curcio, Annalisa; Casadei..., Roberto; Stella, Franco; Ercolani, Giorgio; Gianni, Caterina; Sirico, Marianna; Cima, Simona; Sarti, Samanta; Cecconetto, Lorenzo; Di Menna, Giandomenico; De Giorgi, Ugo | 2023-01-01 | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | - | 1.01 Articolo in rivista | 2023-Merloni (Ther Adv Med Oncol)- Oligometastatic breast cancer REVIEW.pdf |
| The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer | Schepisi G.; Gianni C.; Palleschi M.; Bleve S.; Casadei C.; Lolli C.; Ridolfi L.; Martinelli G.; ...De Giorgi U. | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | - |
| Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer | Gianni C.; Palleschi M.; Merloni F.; Bleve S.; Casadei C.; Sirico M.; Di Menna G.; Sarti S.; Cecc...onetto L.; Mariotti M.; De Giorgi U. | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | Potential Impact of Preoperative Circulating Biomarkers.pdf |
| Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology | Merloni F.; Palleschi M.; Gianni C.; Casadei C.; Curcio A.; Romeo A.; Rocchi M.; Cima S.; Sirico ...M.; Sarti S.; Cecconetto L.; Mariotti M.; Di Menna G.; De Giorgi U. | 2023-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | Merloni_2023.pdf |
| Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical Trial. | Munzone E, Regan MM, Cinieri S, Montagna E, Orlando L, Shi R, Campadelli E, Gianni L, Palleschi M..., Petrelli F, Bengala C, Generali D, Collovà E, Puglisi F, Cretella E, Zamagni C, Chini C, Ruepp B, Loi S, Colleoni M; International Breast Cancer Study Group (IBCSG). | 2023-01-01 | JAMA ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives | Sirico, Marianna; Virga, Alessandra; Conte, Benedetta; Urbini, Milena; Ulivi, Paola; Gianni, Cate...rina; Merloni, Filippo; Palleschi, Michela; Gasperoni, Marco; Curcio, Annalisa; Saha, Debjani; Buono, Giuseppe; Muñoz, Montserrat; De Giorgi, Ugo; Schettini, Francesco | 2023-01-01 | CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY | - | 1.01 Articolo in rivista | Sirico_Neoadjuvant endocrine therapy for luminal breast tumors_2023_january.pdf |
| An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy | Roberta Maltoni; Andrea Roncadori; William Balzi; Massimiliano Mazza; Fabio Nicolini; Michela Pal...leschi; Paola Ulivi; Sara Bravaccini | 2024-01-01 | BIOMEDICINES | - | 1.01 Articolo in rivista | biomedicines-12-00498-v2.pdf |
| Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): Pilot study with 18F-Fluoroestradiol (18F-FES) CT/PET | A. Gennari, E. Brain, A. De Censi, O. Nanni, R. Wuerstlein, A. Frassoldati, J. Cortes, V. Rossi, ...M. Palleschi, J.L. Alberini, F. Matteucci, A. Piccardo, G. Sacchetti, H. Ilhan, F. D’Avanzo, B. Ruffilli, S. Nardin, M. Monti, M. Puntoni, V. Fontana, L. Boni, N. Harbeck, | 9999-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study | Botticelli A, Caputo R, Scagnoli S, Pisegna S, De Laurentiis M, Curigliano G, Lambertini M, Panta...no F, Palazzo A, Paris I, Vernieri C, Tedesco B, Giampaglia M, Palleschi M, Ballatore Z, Alesini D, D'Auria G, Fabbri A, Rossi L, Verrazzo A, Scafetta R, Marinelli D, Sposetti C, Barberi V, Strigari L, Marchetti P, Santini D, Fabi A. | 9999-01-01 | THE ONCOLOGIST | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile